PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
35234137-3	2022	The discovery of new scaffold molecules, a pyrano-1,3-oxazine derivative (NSC 328111; NS5) and phenanthridinone-based derivatives (L10 and its core moiety L10a), as inhibitors of BRD2 bromodomains BD1 and BD2, respectively, has recently been reported.	phenanthridone	95-111	immunoglobulin kappa variable 3-7 (non-functional)	Homo sapiens	155-159	
28696179-3	2018	We have recently reported the discovery of a new scaffold of the phenanthridinone-based inhibitor (L10) of the second bromodomain of BRD2 (BRD2-BD2).	phenanthridone	65-81	immunoglobulin kappa variable 3-7 (non-functional)	Homo sapiens	99-102	
28696179-7	2018	Next, to confirm whether phenanthridionone scaffold is a new inhibitor family of BRD2-BD2, we have determined the crystal structure of BD2 in complex with 6(5H)-Phenanthridinone (a core moiety of L10), refined to 1.28 A resolution.	phenanthridone	155-177	immunoglobulin kappa variable 3-7 (non-functional)	Homo sapiens	196-199